Protein acetylation is a rapid mechanism for control of protein function. Acetyl-CoA synthetase (AMPforming, Acs) is the paradigm for the control of metabolic enzymes by lysine acetylation. In many bacteria, type I or II protein acetyltransferases acetylate Acs, however, in actinomycetes type III protein acetyltransferases control the activity of Acs. We measured changes in the activity of the Streptomyces lividans Acs (SlAcs) enzyme upon acetylation by PatB using in vitro and in vivo analyses. In addition to the acetylation of residue K610, residue S608 within the acetylation motif of SlAcs was also acetylated (PKTRSGK 610 ). S608 acetylation rendered SlAcs inactive and non-acetylatable by PatB. It is unclear whether acetylation of S608 is enzymatic, but it was clear that this modification occurred in vivo in Streptomyces. In S. lividans, an NAD 1 -dependent sirtuin deacetylase from Streptomyces, SrtA (a homologue of the human SIRT4 protein) was needed to maintain SlAcs function in vivo. We have characterized a sirtuin-dependent reversible lysine acetylation system in Streptomyces lividans that targets and controls the Acs enzyme of this bacterium. These studies raise questions about acetyltransferase specificity, and describe the first Acs enzyme in any organism whose activity is modulated by O-Ser and N E -Lys acetylation.
Introduction
Control of protein function by chemical modifications is widespread in biology. Such modifications are diverse, including phosphorylation, hydroxylation, automodification, methylation, glycosylation, sumoylation, ubiquitination, prenylation, ADP-ribosylation and acylation (Walsh, 2006) . Protein acylation itself is also diverse since acyl chains can vary in length, can have one or more carboxylate functional groups, the carbon skeleton may or may not be unsaturated and the moieties can be used to generate O-acylated or N-acylated derivatives (Chen et al., 2007; Garrity et al., 2007; Guan and Fierke, 2011; Wagner and Payne, 2013) .
Here, we investigated the function of GCN5-related N-acetyltransferases (GNATs) (PF00583) from actinomycetes. Some GNATs control the activity of acetyl-CoA (AMP-forming) synthetases (Acs), which are the paradigm of metabolic enzymes whose activities are controlled by sirtuin-dependent, reversible lysine acetylation (sRLA) (Starai et al., 2002; EscalanteSemerena, 2004b, Chan et al., 2011; Crosby and Escalante-Semerena, 2014) . Briefly, AMP-forming Acs enzymes (EC 6.2.1.1) of all domains of life catalyze the reaction shown in reactions 1 and 2. The reactions are reversible as long as pyrophosphate is not hydrolyzed to o-phosphate by pyrophosphatase (reaction 3). acetate1ATP!acetyl2AMP1PP i ðDG 0 5 10:04 kJ=molÞ ð1Þ (Frey and Arabshahi, 1995) acetyl2AMP1CoA!acetyl2CoA 1AMPðDG 0 5 255:65 kJ=molÞ ð2Þ (Frey and Arabshahi, 1995) PP i 1H 2 O!2P i ðDDG 0 5 2 21:92 kJ=molÞ ð3Þ (Thauer et al., 1977) In a cell lacking sirtuin deacetylase, Acs is acetylated by a protein acetyltransferase (Pat) enzyme effectively abolishing reaction 1 (Starai and Escalante-Semerena, 2004b) .
Acs proteins across all domains of life are very similar in length (650-700 residues) and contain 10 conserved regions named A1-A10 (Starai and EscalanteSemerena, 2004a; Gulick, 2009) . Region A10 contains the active-site lysine that is modified by GNATs (Starai et al., 2002) .
Given the relevance of Acs to central metabolism, it is not surprising that the activity of Acs orthologues in cells of all domains of life is under sRLA control (Schwer et al., 2006; Castano-Cerezo et al., 2011; Xu et al., 2011; You et al., 2014) . There are exceptions, however. For example, the Acs enzyme of Streptomyces lividans (SlAcs) is very weakly acetylated by the type II protein acetyltransferase A enzyme (SlPatA) of this bacterium (Tucker and Escalante-Semerena, 2013) . This observation is not due to SlPatA being a poor enzyme, because SlPatA can effectively acetylate the Salmonella enterica Acs (SeAcs) enzyme (Tucker et al., 2014a (Tucker et al., , 2014b . These results are intriguing, because SlAcs and SeAcs share 52% end-to-end identity and an identical acetylation motif (PKTRSGK).
Recent work with the actinomycete Micromonospora aurantiaca provided insights into why SlPatA may not acetylate SlAcs as efficiently as expected. In the alluded work, Xu et al. (2014) identified a GNAT that acetylated the Acs enzyme of M. aurantiaca. This M. aurantiaca GNAT has two domains, a catalytic domain at the C-terminus, and an allosteric ACT-domain (ACT standing for aspartate kinase, chorismate mutase and TyrA, named after the proteins that contain the domain) at the N-terminus. Members of this type of GNATs are referred to as type III or ACT-Pats and they have only been found in actinomycetes (Hentchel and Escalante-Semerena, 2015) . The regulatory domain of type III protein acetyltransferases are substantially smaller (400 residues) than those in type I and II protein acetyltransferases (700 residues), which are found in actinomycetes and other microorganisms (Supporting Information Fig. S1 ) (Hentchel and Escalante-Semerena, 2015) . Type I protein acetyltransferases have the large regulatory domain on the N-terminus, with type II acetyltransferases having the large regulatory domain on the C-terminus (Supporting Information Fig S1) . Currently, the regulatory function of this domain is unknown but shares homology to NDP-forming CoA ligases (Starai and EscalanteSemerena, 2004b) .
Here, we show that the MaACT-Pat enzyme (hereafter referred to as MaPatB) acetylates and deactivates SlAcs, and that the MaPatB homologue from Streptomyces lividans (SlPatB) can also acetylate SlAcs in vivo. Unexpectedly, we found that in S. lividans, SlAcs was acetylated at two sites within the acetylation motif. One modification was on residue S608 located at the 22 position relative to residue K610 of the acetylation motif, which was also acetylated. SlAcs was acetylated at S608 only when purified from S. lividans, but the enzyme had poor activity in vitro and could not be acetylated by MaPatB. These effects were reversed when a variant of SlAcs (SlAcs S608T ) was purified from S. lividans. That is, SlAcs S608T isolated from S. lividans was active and was acetylated by MaPatB. SlAcs isolated from E. coli was not acetylated at either Ser or Lys, suggesting that the E. coli PatZ enzyme (Castano-Cerezo et al., 2011) could not acetylate K610 of SlAcs, and that E. coli lacked the enzyme that modifies S608. At present, it is unclear whether or not S608 acetylation is enzymatic.
Lastly, quantification of SlAcs activity in S. lividans strains lacking either of its putative deacetylases (i.e., LdaA, SrtA, CobB) suggested that the SrtA sirtuin of this bacterium was likely responsible for maintaining SlAcs active in vivo via lysine deacetylation. To our knowledge, this is the first example of an acyl-CoA (AMP-forming) synthetase whose function is regulated by O-and N-acetylation.
Results
The Micromonospora aurantiaca MaPatB enzyme acetylates Streptomyces lividans acetyl-CoA synthetase (SlAcs) in vitro Previous work from our laboratory showed that SlPatA (a type II Pat, Supporting Information Fig. S1 ) did not recognize SlAcs as substrate, but it did acetylate the acetoacetyl-CoA synthetase (SlAacS) from the same organism (Tucker and Escalante-Semerena, 2013) . Recent work with Micromonospora aurantiaca identified a type III Pat enzyme containing an ACT-domain (PF01842, MaPatB, Fig. 1, Supporting Information Fig.  S1 ) that acetylated its cognate Acs (Micau_0428, hereafter MaAcs) (Xu et al., 2014) . Analysis of the genome of S. lividans identified locus EFD70633 as one encoding a homologue of MaPatB (41% identity, Fig. 1 ; hereafter SlPatB). Results in Fig. 2A show that SlPatA did not recognize MaAcs or SlAcs as substrates, but it did recognize SlAacS, a bona fide substrate of SlPatA (Tucker and Escalante-Semerena, 2013) , indicating that SlPatA was active. In contrast, MaPatB acetylated SlAcs at residue K610 (Fig. 2B, lanes 2, 3, 4) . These results were similar to those obtained with control experiments where MaPatB was incubated with its known substrate MaAcs (Fig. 2B, lanes 5, 6, 7) . Despite the level of identity between MaPatB and SlPatB ( Fig. 1) , SlPatB failed to acetylate SlAcs or MaAcs under the conditions tested (Fig. 2B, lanes 9, 10) .
Effects of acetylation on SlAcs activity
Since SlPatB did not acetylate SlAcs in vitro but MaPatB did (Fig. 2B) , we used MaPatB to assess the effect of Micau_0428) and SlPatB (EFD70633), were aligned using ESPrit 3.0 (Robert and Gouet, 2014) with default parameters. MaPatB and SlPatB share 41% identity (BLASTp) and the active site glutamate of these proteins is indicated by the red asterisk.
Dual O-Ser, N-Lys acetylation control of an acyl-CoA ligase 579 acetylation on SlAcs activity. The SlAcs enzyme used in the experiments described below was isolated from E. coli. Under the conditions tested, SlAcs activity decreased proportionally to the amount of MaPatB used in the experiment (0-3 lM), but leveled off after an 50-60% decrease even in the presence of excess MaPatB (Fig. 3) . In these experiments, a specific activity of 30 lmol AMP min 21 mg 21 was considered to be 100%. The observed decrease in activity was consistent with MaPatB acetylation on MaAcs (Xu et al., 2014) . The limited reduction in SlAcs activity was unusual in that homologues from other bacteria are > 80% deactivated upon acetylation (Starai and Escalante-Semerena, 2004b; Gardner et al., 2006; Gardner and EscalanteSemerena, 2008; Crosby et al., 2010; Crosby et al., 2012a Crosby et al., , 2012b Tucker and Escalante-Semerena, 2013) . We investigated possible reasons for the limited deactivation of SlAcs.
The acetylation state of SlAcs purified from S. enterica
To determine whether the loss of SlAcs activity was due to the acetylation of residue K610, we analyzed the acetylation state of SlAcs proteins synthesized by S. enterica using rabbit polyclonal anti-acetyllysine (a-AcK) antibodies. Results of control experiments with nonacetylated SlAcs and in vitro acetylated SlAcs (acetylated by MaPatB) showed that AcK was readily detected under the conditions tested (Fig. 4, ) was calculated using a continuous spectrophotometric assay as described in Experimental procedures. The activity of SlAcs measured after incubation in the absence of MaPatB was set as a value of 100% activity and SlAcs activity was compared with increasing amounts of MaPatB as indicated by the y-axis. Error bars represent standard deviation. Experiment was repeated three times in technical triplicate. Fig. 4 . SlAcs is acetylated in S. enterica strains that synthesize active PatB acetyltransferases. Cell lysates were obtained from Dacs/pSlAcs strains expressing the acetyltransferase as indicated above each lane. pSlPatB E366Q and pMaPatB E269Q refer to plasmids carrying alleles that encode inactive forms of SlPatB or MaPatB, respectively. Acetylation state of SlAcs from lysates (left panel, SDS-PAGE) was analyzed by western blot analysis using anti-acetyllysine (right panel, a-K Ac ). In vitro acetylated and non-acetylated SlAcs were used as positive and negative controls respectively. SlAcs is the band at 72 kDa. CFEs, cell-free extracts.
Discovery of O-Ser acetylation in SlAcs
To determine acetylation state of SlAcs when it is synthesized in S. lividans, H 6 -SlAcs WT protein was purified from S. lividans. Unexpectedly, the specific activity of SlAcs WT enzyme isolated from S. lividans (2 lmol AMP min 21 mg 21 ) was 20-to 30-fold lower than that of SlAcs WT purified from E. coli (Fig. 5A ). In fact, the activity of SlAcs purified from S. lividans was similar to that of an inactive SlAcs variant (SlAcs
K610A
; Fig. 5A ). Results from size-exclusion chromatography experiments (column volume 25 ml with a flow rate of 0.5 ml min 21 ) showed that the retention time and peak distribution of SlAcs purified from S. lividans (24 min) was unchanged from that of SlAcs purified from E. coli (24 min, Supporting Information Fig. S3 ), suggesting that the proteins were probably not misfolded. Surprisingly, the SlAcs WT protein purified from S. lividans strains was not acetylated by MaPatB in vitro compared to the positive control (Fig. 5B , lane 2 vs. 3.). To determine whether this observation was due to unknown posttranslational modifications on SlAcs, LC/MS/MS peptide fingerprinting was performed on SlAcs purified from different sources, namely (i) SlAcs purified from E. coli and incubated with MaPatB 1 AcCoA, (ii) SlAcs purified from E. coli and incubated with AcCoA but no MaPatB and (iii)
SlAcs purified from S. lividans. SlAcs WT protein purified from S. lividans was acetylated at residue serine (S608) and residue K610 (Fig. 6A ). In contrast, residue S608 was not acetylated in SlAcs WT protein purified from E. coli, and this protein could be acetylated by MaPatB at residue K610 as shown by mass spectrometry (Fig. 6B) . The SGKIMR peptide of untreated SlAcs protein purified from E. coli was not detected in the LC/MS/MS most likely because trypsin cleaved this peptide at K and R, rendering it too small for detection (data not shown).
In the past, our group reported that single substitutions in the acetylation motif can render an acyl-CoA synthetase non-acetylatable (Crosby and EscalanteSemerena, 2014 isolated from E. coli (Fig. 7 , red vs. gray bar). From an enzyme functionality standpoint, this result showed that although Ser and Thr have a hydroxyl group in their side chains that could be modified, the Ser side chain was acetylated, inactivating the enzyme, while the SlAcs S608T protein was not, resulting in active enzyme. The SlSrtA enzyme (a SIRT4-like sirtuin) deacetylates SlAcs Ac in S. lividans
To determine whether acetylated SlAcs S608T could be enzymatically deacetylated, we looked for genes in the S. lividans genome putatively encoding protein deacetylases; we found three such genes (ldaA, srtA and cobB). One of them encoded a homologue of the NAD 1 -dependent SIRT5 deacetylase, (a homologue of SeCobB), another one encoded a homologue of the NAD 1 -dependent SIRT4 sirtuin, and a third one encoded a homologue of the Zn-dependent, acetateforming RpLdaA deacetylase (Crosby et al., 2012a; Tucker and Escalante-Semerena, 2013 ). H 6 -SlAcs S608T protein was purified from five S. livid- (Mikulik et al., 2012) . Unfortunately, S. lividans
SrtA and CobB deacetylases were not active when purified from E. coli (Tucker and Escalante-Semerena, 2013) . Based on the in vivo data reported in Fig. 8 we propose that SrtA is likely the deacetylase that used SlAcs Ac as substrate in S. lividans.
Acetylation of the SlAcs S608T variant protein by MaPatB decreases its activity
To assess the effect of acetylation on SlAcs S608T activity, SlAcs S608T and SlAcs WT were purified from E. coli and were acetylated (5 lM) in vitro by MaPatB (1 lM). When SlAcs WT was acetylated, it lost 20% activity compared to the non-acetylated control (Fig. 8B ). These results are comparable to the data in Fig. 3 , where a 20% decrease in SlAcs WT activity was seen with similar ratios of SlAcs to MaPatB (i.e., 1:5) In contrast, when SlAcs S608T was acetylated under the same conditions it lost 80% activity ( Fig. 8B ). These results raised important questions about the control of CoA synthetases in S. lividans and the potential sequential control of CoA synthetases through posttranslational modifications of multiple residues. These data also raised questions about how this protein may be deacetylated, and if the deacetylation of serine or lysine is dependent on deacetylation of the subsequent residue. These results are discussed below.
Initial in vitro studies of protein substrate specificity among Pat enzymes
The differences in SlAcs acetylation by SlPatA and MaPatB ( Fig. 2A and B ) raised questions about the specificity of Pat enzymes for Acs substrates. To further examine this specificity, SlAcs was incubated with other Pat enzymes. We found that Rhodopseudomonas palustris Pat (RpPat, a type I enzyme) efficiently acetylated SlAcs (Supporting Information Fig. S4A , lanes 2-4) compared to the positive control of RpPat with its known substrate RpBadA (Supporting Information Fig. S4A , lane 8) (Crosby et al., 2010) . In contrast, incubation of SlAcs with Salmonella enterica Pat (SePat) yielded a signal that was only 16% as strong as the signal obtained with SeAcs, a bona fide substrate of SePat (Supporting Information Fig. S4, lane 8) . Although MaAcs and SlAcs are 76% identical (Supporting Information Fig. S2 ), SePat acetylated MaAcs more efficiently (fivefold stronger signal than SlAcs) (Supporting Information Fig. S4B , lanes 2 vs. 5). With the exception of SePat, all other Pat enzymes tested acetylated MaAcs and SlAcs very similarly (Fig. 2) .
In vivo evidence supports the observed difference in substrate specificity among Pat enzymes
We performed in vivo experiments to determine whether the differences in protein substrate specificity of Pat enzymes observed in vitro, could be replicated under conditions where Acs activity was required for growth. To do this, we grew S. enterica strains with low concentrations of acetate (10 mM), a condition where Acs activity is needed (Starai and Escalante-Semerena, 2004a) . In wild-type S. enterica, the absence of CobB results in a substantial decrease in cell growth with 10 mM acetate (Starai et al., 2003) . Such a phenotype is due to the acetylation of Acs by Pat (Starai and Escalante-Semerena, 2004b) . Surprisingly, a S. enterica Dacs DcobB pat 1 strain carrying a plasmid encoding SlAcs grew better than the acs 1 cobB 1 pat 1 strain with 10 mM acetate (Supporting Information Fig. S5 , compare gray squares, black circles, white diamonds). These results were consistent with the idea that SePat, which was present in all strains tested, did not acetylate SlAcs in vivo to the point of affecting the ability of the cell to grow with low acetate concentrations. In contrast, when the Dacs DcobB pat 1 strain carrying a plasmid encoding SlAcs also carried the pSlPatB plasmid growth was delayed for 20 h, after which the cultures grew at a rate comparable to that of the wild-type strain and reached full density (Supporting Information Fig S5, black vs. white circles).
Exploring the specificity of Pat enzymes for SlAcs using an in vivo heterologous system
To monitor SlAcs activity and its control by different Pat enzymes in vivo, we used Salmonella enterica strains in which the posttranslational control of Acs and the effects of the absence of control elements (i.e., Pat, CobB) on growth have been extensively characterized (Starai et al., 2002; Starai et al., 2003; Starai and EscalanteSemerena, 2004b; Chan et al., 2011) . Several genes were cloned, introduced into a S. enterica Dacs strain. The growth behavior with 10 mM acetate as the sole source of carbon and energy was monitored as a function of time. The presence of the pat 1 allele in all strains was not a concern since SePat did not acetylate SlAcs extensively in vitro (Supporting Information Fig. S4B , which were cloned into a compatible arabinose inducible vector encoding chloramphenicol resistance and the resulting plasmids were transformed into strain JE21742 (Dacs/ pSlAcs). The resulting strains were grown in minimal medium containing acetate (10 mM). Under those conditions cell growth required Acs function. We predicted that acetylation of Acs would lower its activity reducing the growth rate and final cell density of the cultures.
In Fig. 9A , the behavior of positive-and negativecontrol strains growing in minimal medium with low acetate (10 mM) as the sole source of carbon and energy is shown by black circles (acs 1 ) and grey squares (Dacs), respectively. When the Dacs strain synthesized SlAcs, growth occurred without delay (Fig. 9A , white diamonds), indicating that SlAcs was functional. Notably, growth of the Dacs strain that synthesized SlPatA and SlAcs was not different than that of the Dacs strain that only synthesized SlAcs (Fig. 9A , white diamonds vs. grey triangles). These results suggested that neither SePat nor SlPatA inactivated SlAcs. In contrast, cultures of Dacs strains that synthesized SlAcs and either SlPatB or MaPatB displayed an 30-h long lag phase before the onset of exponential growth (Fig. 9A , white diamonds vs. grey diamonds or white circles). We hypothesized that the observed lag phase was associated with an increase in SlAcs acetylation, which would result in lower SlAcs activity. To test this idea, the same strains were grown with acetate, cells were collected at mid-log (OD 630 0.15) and lysed and SlAcs activity was quantified. SlAcs activity decreased by 10% in Dacs/pSlAcs cells harboring a plasmid encoding SlPatA compared to the vector-only control (Fig. 9B) . In contrast, a 60-70% decrease in SlAcs activity was measured when the enzyme was purified from strain Dacs/pSlAcs/pSlPatB or from strain Dacs/pSlAcs/pMaPatB. These percent activities were relative to that of SlAcs purified from cells that did not express an acetyltransferase (Fig. 9B, black  bar) . These results were consistent with the idea that A. The gene coding for SlAcs was cloned into cloning vector pCV1 and introduced into a S. enterica Dacs strain carrying genes coding for acetyltransferases of interest cloned into cloning vector pCV3. Overnight cultures were grown in NB 1 antibiotic. Cells were sub-cultured (1% v/v) and grown on NCE minimal medium supplemented with acetate (10 mM). Growth curves were obtained in technical triplicate and was repeated three times using a microplate reader (BioTek instruments). Error bars represent standard deviation of technical triplicates. B. Cells grown in 1 liter of same medium conditions from A were harvested and lysed and SlAcs specific activity (lmol AMP min 21 mg 21 ) was quantified using a continuous spectrophotometric assay. SlAcs was isolated from strains containing plasmids listed below bars. Error bars represent standard deviation of technical triplicates. Asterisks represent significance compared to vector control by calculating p value using an unpaired t-test, *** represents a p value below 0.0005, **** represents a p value below 0.00005 and ns represents no significance.
Dual O-Ser, N-Lys acetylation control of an acyl-CoA ligase 585 that the above-mentioned lag phase was likely due to a decrease in SlAcs activity due to acetylation. These results also suggested that although SlPatB was not active in vitro, it did acetylate SlAcs in vivo, thereby reducing its activity.
Discussion
The fact that the AMP-forming acetyl-CoA synthetase from Streptomyces lividans (SlAcs) was poorly acetylated by SlPatA (Tucker and Escalante-Semerena, 2013) was the driving force for the work presented in this paper. Here, we show that SlAcs activity is controlled by sirtuin-dependent reversible lysine acetylation (sRLA), and that the enzyme responsible for this modification is a type III protein acetyltransferase thus far found only in actinomycetes. The sRLA control of SlAcs activity is novel because of the unprecedented involvement of an O-acetylation modification of the side chain of a serine residue close (position 22) to the lysyl chain that is typically acetylated in AMP-forming acyltransferases. Serine and threonine acetylation in bacteria was only recently reported, with the paradigm acetyltransferase being YopJ from Yersinia pestis (Mukherjee et al., 2007) . YopJ acetylates lysine, threonine and serine residues of host kinases (Mittal et al., 2010) . While YopJ is a prokaryotic acetyltransferase that O-acetylates a eukaryotic protein, SlAcs is the first example of a prokaryotic AMP-forming acyl-CoA synthetase that is controlled by O-Ser and N ELys acetylation. Additionally, a recent acetylome study in Mycobacterium tuberculosis identified many acetylated serine residues on a myriad of proteins (Birhanu et al., 2017) . Although the enzyme responsible for acetylating serine residues has not yet been identified in M. tuberculosis, these studies highlight the prevalence of O-serine acetylation in prokaryotes, an area that needs further investigation.
Type III protein acetyltransferases acetylate Acs in Actinomycetes
In several Alpha-and Gamma-proteobacteria, AMPforming Acs enzymes are regulated by type I protein acetyltransferases [for a review see (Hentchel and Escalante-Semerena, 2015) ]. Here, we identified the SlPatB enzyme (a type III protein acetyltransferase) of Streptomyces lividans as the enzyme that controls the activity of SlAcs at the expense of AcCoA (Fig. 2) . SlPatB is a homologue of MaPatB from Micromonospora aurantiaca, which was shown to be allosterically regulated by cysteine and arginine (Xu et al., 2014) . It is likely that Acs control in S. lividans is further affected by physiological conditions that modulate cysteine and arginine metabolism, given that fact that MaPatB activity is allosterically regulated by these two amino acids. At present, it is unclear whether or not SlPatB is allosterically controlled because this enzyme was not active under the in vitro conditions tested. Bioinformatics analyses show that only genomes of actinomycetes encode type III protein acetyltransferases, raising important questions about the possible link between amino acid metabolism and protein acetylation in these bacteria.
O-Serine and N E -lysine acetylation controls the activity of SlAcs in Streptomyces lividans
The regulation of Acs in S. lividans appears to be more complex than that of Acs homologues found in other bacteria. To our knowledge, SlAcs is the first AMPforming AcCoA synthetase whose activity is posttranslationally controlled by O-Ser and reversible N E -Lys acetylation.
SIAcs synthesized by S. lividans was acetylated at the expected Lys residue within the acetylation motif (site 0), and at residue S608 located two positions upstream the Lys acetylation site (site 22; Fig. 6A ). At this point, it is not clear what the order of acetylation may be, however, we propose that two different acetyltransferases modify SlAcs in S. lividans, since synthesis of SlAcs in E. coli did not yield enzyme acetylated at S608, suggesting that E. coli lacks the O-acetyltransferase that modifies residue S608 (Fig. 6B) . Although chemical (i.e., nonenzymatic) serine acetylation is rare, at present we cannot rule out this possibility. It appears unlikely that this would be the case, since SlAcs isolated from E. coli S608 was not acetylated. Further studies on S608 acetylation in Streptomyces are needed.
We suggest that in S. lividans full downregulation of SlAcs activity only occurs when S608 is acetylated (Fig.  8B) . We suggest that this is the case because when we attempted to acetylate SlAcs isolated from E. coli, SlAcs activity was only decreased by 20-40%, even after extended incubation with the acetyltransferase. Since E. coli does not acetylate S608, the acetyltransferase can modify K610. In contrast, SlAcs isolated from S. lividans was modified at residue S608 (Fig. 6A ) and lacked activity (Fig. 5) . The absence of activity correlated with the presence of acetylated serine, because when serine variant SlAcs S608T was isolated from S. lividans strong SlAcs activity was measured (Fig. 7A ). The results with SlAcs S608T also suggest that the putative serine acetyltransferase cannot recognize threonine as its substrate. Acetylation of S608 is of interest given the location of this residue within the acetylation motif found in CoA synthetases [PX 4 GK, (Crosby and Escalante-Semerena, 2014) ]. In SlAcs, the acetylation motif is PKTRSGK 610 , with the modified serine and lysine residues shown in bold typeface. Based on the data reported here, it appears like there are several layers of control of SlAcs in S. lividans. At present is not known whether S608 acetylation is reversible, but if it were, the identification of the S608 Ac deacetylase would be an important step towards understanding the integration of two reversible acetylation/deacetylation events that control S608 and K610 modification. Why would such a mechanism of Acs posttranslational control be needed in Streptomyces? Is this control mechanism used to modulate the activity of other enzymes in prokaryotes or eukaryotes? These and other interesting questions warrant further investigation in this area of Streptomyces physiology.
An opportunity to identify determinants that play a critical role in acyltransferase specificity
Questions regarding how acyltransferases recognize their protein targets are of interest. We have published structural studies aimed at identifying residues contributing affecting the recognition and specificity of SlPatA for SeAcs (Tucker et al., 2014a,b) . One limitation of the alluded work was that it was performed with proteins from different sources. The studies reported, here, open the door for structural work involving enzymes partners from the same organism. A better understanding of the specificity of acyltransferases for their protein targets may help identify such targets.
Deacetylation of SlAcs in Streptomyces
The S. lividans genome codes for three deacetylases, two of which are NAD 1 -dependent sirtuin deacylases (Sauve, 2010) . The two sirtuins in this bacterium are different from each other. One of them, SlCobB (formerly CobB2), is homologous to human SIRT5 a known demalonylase, desuccinylase (Matsushita et al., 2011) . The other, SlSrtA (formerly CobB1) is homologous to human SIRT4, a known ADP-ribosyltransferase (Haigis et al., 2006) . SIRT5-like enzymes are the best characterized family of sirtuins in bacteria (e.g., SeCobB, RpSrtN, EcCobB).
Results presented in Fig. 8A suggest that SlSrtA is responsible for maintaining SlAcs deacetylated (thus, active) in vivo. Unfortunately, the function of putative deacetylases was not studied in vitro due to difficulties in obtaining active enzymes. At present, it is unclear why SlCobB and SlSrtA proteins were inactive in isolation. However, results of in vivo experiments show that SlSrtA is an active participant in the regulation of SlAcs activity, hence, offering avenues for future research.
Prior to this publication there were no known substrates for S. lividans protein deacylases.
Experimental procedures
Bacterial strains, culture media, chemicals and sequencing methods
All strains used in this study are listed in Table 1 . Escherichia coli C41 (kDE3) (Miroux and Walker, 1996) and DH5a (New England Biolabs) strains were grown in lysogeny broth (LB, Difco) at 378C. Salmonella strains used for growth analysis were derivatives of Salmonella enterica subsp. enterica sv Typhimurium strain LT2 (hereafter S. enterica) and grown at 378C in nutrient broth (NB, Difco) with NaCl (85 mM), or no-carbon essential (NCE) minimal medium (Berkowitz et al., 1968) supplemented with sodium acetate (10 mM), L-methionine (0.5 mM), MgSO 4 (1 mM) and trace minerals (Balch and Wolfe, 1976) . When added to the medium antibiotics were present at the following concentrations: ampicillin, 100 lg ml
21
; chloramphenicol, 20 lg ml
. Streptomyces strains were all derivatives of Streptomyces lividans strain TK24. ISP-2 medium (Shirling and Gottlieb, 1966) or R2YE medium (Kieser et al., 2000a,c) was used to culture S. lividans on solid medium. Liquid cultures were grown on yeast extract-malt extract (YEME) rich medium in baffled flasks (cultures under 200 ml) or with marine-grade stainless steel springs (NMMP) (cultures over 500 ml) to reduce cell clumping. Strains were grown 2-5 days at 308C at 220-250 r.p.m. Antibiotics were used at the following concentrations: thiostrepton, 10 lg ml 21 , ampicillin, 100 lg ml
, chloramphenicol, 20 lg ml
. All chemicals were purchased from Fisher Chemical Co. unless noted otherwise; chloramphenicol, L(1)-arabinose (SigmaAldrich); and isopropyl b-D-1-thiogalactopyranoside (IPTG, IBI Scientific). All restriction enzymes were purchased from Thermo Scientific TM with the exception of BspQI (New England Biolabs).
Molecular techniques
DNA manipulations were carried out using standard molecular techniques (Elion et al., 2007) . DNA was amplified using Pfu Ultra II Fusion DNA polymerase (Agilent) or Phusion High-Fidelity DNA Polymerase (New England Biolabs). Site-directed mutagenesis was performed using the Quikchange TM Site Directed Mutagenesis protocol (Agilent). Plasmids were purified using the Wizard Plus SV Miniprep kit (Promega) and PCR products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega). DNA sequencing was performed at the Georgia Genomics Facility. Primers were synthesized from Integrated DNA Technologies and are listed in Table 2 .
Construction of plasmids for protein production and complementation
The following genes were amplified from purified genomic DNA using primers listed in Table 3 : Streptomyces lividans Dual O-Ser, N-Lys acetylation control of an acyl-CoA ligase 587 TK24 acs (EFD68454), patA (EFD66247), patB (EFD70633), aacS (EFD70521), Micromonospora aurantiaca ATCC 27029 acs (Micau_0428), patB (Micau_1670), Salmonella enterica LT2 pat (STM2651), acs (STM4275), Rhodopseudomonas palustris CGA009 badA (RPA0661) and pat (RPA4240). For Salmonella complementation studies, the start codons of S. lividans acs and patA genes (GTG, TTG, respectively) were changed to ATG. The DNA fragments and corresponding plasmids were digested with BspQI and cloned using protocols described elsewhere described (Galloway et al., 2013; VanDrisse and EscalanteSemerena, 2016) .
The resulting plasmids were: pSlAcs1, pSlPatA1, pSlAacS1, pSlPatB1, pMaAcs3, pMaPatB3, pRpPat2, pRpBadA3, pSeAcs65 and pSePat8. All plasmids directed the synthesis of proteins fused to an N-terminal H 6 tag (with the exception of pRpPat2, which was fused to an Nterminal H 6 -MBP tag). All tags were cleavable by recombinant tobacco etch virus (rTEV) protease purified as described (Blommel et al., 2007) . Plasmids that directed the synthesis of SlAcs K610A (pSlAcs2), and MaAcs
K620A
(pMaAcs5) variants were generated from plasmids pSlAcs1 and pMaAcs3. The resulting plasmids (i.e., pSlAcs50, pSlPatB4, pSlPatA57, pMaAcs1 and pMaPatB) were used for complementation in Salmonella. For purification from Streptomyces, pSlAcs31 or pSlAcs52 directed the synthesis of a protein fused to an N-terminal H 6 -tag from plasmid pSE34. For identification of plasmid backbones and antibiotic markers for the above-mentioned constructs, refer to Table 1 .
Construction of gene deletions in Salmonella enterica
An in-frame deletion of acs in Salmonella enterica was constructed using the phage lambda Red recombinase system as described elsewhere (Datsenko and Wanner, 2000) . Plasmids were transformed into strains as described ( VanDrisse et al., 2017) . In cells that carried two plasmids, pCV1 plasmids were transformed into competent S. enterica cells and selected for on ampicillin. Competent cells harboring pCV1 plasmids were then transformed with pCV3 plasmids, whose inheritance was selected by chloramphenicol resistance. Transformants were streaked onto LB 1 ampicillin and chloramphenicol to select for cells containing both plasmids.
Construction of gene deletions in Streptomyces lividans
In-frame deletions of DldaA, DsrtA and DcobB were generated as described (Martinez et al., 2004) . DNA fragments of 1.5-kb upstream and downstream of the gene of interest 
a. Unless otherwise stated, all strains and plasmid were constructed during the course of these studies.
were amplified from S. lividans TK24 purified genomic DNA. The resulting fragments were cloned into plasmid pKC119 (Bierman et al., 1992) using the In-fusion ND Cloning Kit (Clontech) and transformed into E. coli Stellar competent cells (Clontech). Resulting plasmids were transformed into the E. coli helper strain HB101 harboring pRK2013 (Figurski and Helinski, 1979) . Plasmids were conjugated into S. lividans and plated on mannitol soya (MS) agar (Kieser et al., 2000c) . After 20 h of growth, plates were flooded with apramycin (50 lg ml 21 final concentration for 25 ml of plate in 3 ml of soft nutrient agar) to select for the acquisition of deletion construct plasmids. Apramycin-resistant strains were inoculated into 25 ml YEME 1 apramycin grown in 500 ml baffled flasks at 308C for 4 days. Cells were pelleted, re-suspended and plated on ISP-2 medium 1 apramycin at 428C for 3 days to select for cells that had integrated the plasmids into the chromosome. Apramycin-resistant cells were grown in 25 ml of YEME medium in 500 ml baffled flasks at 308C for 4 days and plated on ISP-2 at 308C to promote loss of plasmid. Isolated colonies were screened on ISP-2 and ISP-2 medium containing with apramycin to screen. Apramycin-sensitive strains were screened by PCR for deletion of ldaA, cobB or srtA.
Protein purification from Escherichia coli or Salmonella enterica
Proteins purified from cells expressing pSlAcs1, pSlAcs2 pSlPatA1, pSlAacS1, pRpBadA3, were obtained from laboratory stocks. Plasmids pSlACT-Pat1, pMaAcs3, pMaAcs5, pMaPatB3, pRpPat2, pSePat8, pSeAcs65 were transformed into E. coli C41k(DE3) pat::kan 1 . The resulting strains were grown overnight in 50-ml cultures in medium containing ampicillin (100 lg ml 21 ), and were sub-cultured 1:100 into 2 liters of lysogeny broth containing ampicillin (100 lg ml
21
). Cultures were grown shaking at 308C to an optical density at 600 nm (OD 600 ) 0.6, and protein synthesis was induced by the addition of IPTG (0.5 mM). Upon induction, cultures were grown at 258C overnight and harvested at 6000 3 g for 15 min at 48C in an Avanti J-2 XPI centrifuge with rotor JLA-8.1000 (Beckman Coulter). Cell pellets were stored at 2808C until used. Pellets were thawed and re-suspended in 50 ml of buffer A [(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer [(50 mM, pH 7.0 at 48C) containing NaCl (500 mM), imidazole (20 mM), lysozyme (1 mg/ml), DNase (1lg/ml) and protease inhibitor phenylmethanesulfonyl fluoride (PMSF, 0.5 mM)]. Cells were lysed on ice by two rounds of sonication (1 min (2s, 50% duty, ea.) using a 550 Sonic Dismembrator (Fischer Scientific) at setting 5. Clarified cell lysates were obtained after centrifugation for 30 min at 48C at 40,000 3 g in a Beckman Coulter Avanti J-25I with JA-25.50 rotor followed by filtration of the supernatant through a 0.45 lm filter (Millipore). Samples were applied at 48C to a pre-equilibrated 1-ml HisPur nickel-nitrilotriacetic acid (Ni-NTA) resin (Thermo Scientific). The column was washed with 10 column volumes (CV) of buffer A, followed by 7 CV of buffer B [HEPES (50 mM, pH 7.0 at 48C)] containing NaCl (500 mM), and imidazole (60 mM). Proteins were eluted with 5 CV of buffer C [HEPES (50 mM, pH 7.0 at 48C)] containing NaCl (500 mM), and imidazole [500 mM]).
Proteins were dialyzed at 48C in decreasing concentrations of NaCl (400 mM, 200 mM and 150 mM) with a final buffer composition of HEPES (50 mM, pH 7.0 at 48C), NaCl (150 mM) and glycerol (20% v/v). Proteins concentration was quantified using a NanoDrop with molecular weights and extinction coefficients of each protein as calculated by inputting protein sequences into ExPASy (ProtParam). Proteins were drop-frozen in liquid nitrogen and stored at 2808C. Purification of SlAcs from S. enterica cells was carried out in the same manner, but the column volume of the nickel resin was 100 ll and 2 liters of cells were grown in NCE minimal medium supplemented with acetate (10 mM) as carbon and energy source and L-(1)-arabinose (100 lM) as inducer. Purification of SlAcs from S. enterica was performed in biological triplicates and the experiment was carried out twice. In vitro protein acetylation assays
Protein acetylation assays were performed as described (Starai and Escalante-Semerena, 2004b) . Briefly, reaction mixtures contained HEPES buffer (50 mM, pH 7.0 at 258C), tris(2-carboxyethyl)phosphine hydrochloride (TCEP; 1 mM), [1-14 C]-acetyl-CoA (20 lM), protein substrate (3 lM) and acetyltransferase (1 lM). Reactions (25 ll total volume) were incubated at 378C for 60 min. Reactions were stopped by the addition of 5 ll of 6x loading dye [60% (v/v) glycerol, Tris-HCl pH 6.8 (0.3 M), EDTA (12 mM), 12% SDS (w/v), 2-mercaptoethanol (0.87 mM), bromophenol blue (0.05%, w/ v)] and heated at 1008C for 10 min. Samples (3 ll) were resolved using SDS-PAGE (Laemmli, 1970) , and visualized by Coomassie Blue R staining (Sasse, 1991) . Gels were dried, exposed overnight to a MultiPurpose phosphor screen (Packard), and imaged using a Typhoon (GE Healthcare). In vitro protein acetylation assays using [1-14 C]-acetyl-CoA were performed in triplicate.
In vitro acyl-CoA synthetase assays Acyl-CoA synthetases (concentrations indicated in figure legends) were incubated with acetyltransferase (concentration indicated in figure legends) with or without acetyl-CoA (60 lM) for 1 h at 378C using reaction conditions described above. Activity of acyl-CoA synthetases was quantified using an NADH-consuming coupled assay (Reger et al., 2007) . Reactions contained HEPES buffer (50 mM, pH 7.0 at 258C), TCEP (1 mM), ATP (2.5 mM), coenzyme A (CoASH, 0.5 mM), MgCl 2 (5 mM), phosphoenol pyruvate (3 mM), NADH (0.1 mM), pyruvate kinase (1 U), myokinase (5 U), lactate dehydrogenase (1.5 U) and organic acid substrate (0.2 mM). All reactions were started by addition of 2 ll of above acetylation reactions (final concentration of acyl-CoA synthetase, 60 nM). Changes in NADH absorbance was monitored at 340 nm for 8 min in a 96-well plate format using a Spectramax Plus UV-visible spectrophotometer (Molecular Devices). Enzyme activities were calculated as described (Garrity et al., 2007) . Data presented, here, were obtained from technical triplicates of one biological replicate, which was repeated in triplicate.
Western blot analysis of His 6 -SlAcs purified from S. enterica Plasmids directing the synthesis of His 6 -SlAcs were transformed into a metE205 ara-9 Dacs Dpat strain (JE11993). Total cell lysates were prepared from 100 ml of S. enterica cells grown on minimal medium supplemented with acetate (10 mM), ampicillin and arabinose (0.1 mM). Cells were pelleted at 6000 3 g for 10 min and resuspended in 10 ml of buffer A (above) with 1 mg ml 21 of lysozyme and 1 lg ml
DNase. Total cell lysates were quantified using a Bradford assay kit (BioRad). From each total cell lysate 7 lg of protein was loaded onto an SDS-PAGE gel. SlAcs purified from E. coli was acetylated in vitro with MaPatB as described above and loaded on the same SDS-PAGE gel. Three gels were loaded, one for Coomasie Blue R staining and two for technical replicates for transfer. Proteins were resolved by SDS-PAGE at 220 V for 45 min and subsequently transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore) using a Trans-Blot Turbo System (BioRad) using BioRad StandardSD mini gel setting (1.0 A, 25 V, 30 min) and transfer buffer (Tris•HCl (25 mM, pH8), glycine (192 mM) and methanol (10% v/v). Membranes were incubated with blocking buffer consisting of condensed milk (12.5% w/v) in 25 ml of phosphate buffered saline with teween 20 (PBST) (10 mM NaH 2 PO 4 (pH 7.2 at 258C), NaCl (0.9% w/v) and . Membranes were probed with polyclonal rabbit a-acetylated lysine antibodies (1:866 dilution into blocking buffer) (Calbiochem) overnight at 48C. Membranes were washed thrice with 20 ml of PBST and goat a-rabbit immunoglobuilin G conjugated to calf intestinal alkaline phosphatase (Pierce) were diluted (1:5000) into blocking buffer and applied to membrane for 1 h at 258C to detect SlAcs Ac . Membranes were washed thrice with 20 ml PBST and signal was detected using nitroblue tetrazolium chloride [19 mg/1 ml of 67% dimethylsulfoxide (DMSO)] and 5-bromo-4-chloro-3'-indolylphosphate ptoluidine salt (9 mg/1 ml of 67% DMSO) (NBT-BCIP).
Protein purification from Streptomyces lividans
Plasmids pSlAcs31 (encoding His 6 -SlAcs) or pSlAcs52 (encoding His 6 -SlAcs S608T ) were introduced into S. lividans strains (wild-type, DldaA, DldaA DcobB and DldaA DcobB DsrtA) by polyethyleneglycol (PEG)-assisted protoplast transformation as described (Kieser et al., 2000b,c) . Transformed cells were plated on R2YE medium and grown at 308C for 20 h. Plates were then flooded with thiostrepton (10 lg ml
21
, final concentration for 25 ml plate volume in 3 ml soft agar nutrient broth) and incubated for 1-2 days at 308C to select for strains harboring plasmids. Cells containing pSlAcs31 or pSlAcs52 were grown in 25 ml YEME medium 1 thiostrepton in 500-ml baffled flasks for 4-5 days at 308C. Cells were harvested by diluting 1:2 into water and centrifuged at 2000 3 g for 10 min. Cell pellets were resuspended in 1-2 ml of YEME medium and 300 ll were plated on multiple MS agar plates. Spores were harvested as described (Kieser et al., 2000a) and counted by serial dilutions plated on ISP-2 medium 1 thiostrepton. Spores (1 3 10 9 /liter) were inoculated into 100 ml YEME medium-1 thiostrepton and grown for 2-3 days at 308C. Cells were harvested by diluting cultures 1:2 into water and centrifuging at 2000 3 g for 15 min. Cells were re-suspended in 30 ml of buffer A (above) with 1 mg ml 21 of lysozyme, 1 lg ml 21 DNase and protease cocktail inhibitor (100 ll, Sigma). Cells were lysed by sonication on ice (46 s total with 2 s on, 2 s off) and cell debris was removed by centrifugation at 45,000 3 g for 30 min. His 6 -SlAcs or His 6 -SlAcs S608T protein was purified as described above using a 200 ll of a Ni-NTA resin (Pierce). SlAcs-containing fractions were combined and dialyzed at 48C for 3 h into HEPES (50 mM, pH 7 at 48C), NaCl (250 mM), followed by a final dialysis in HEPES (50 mM, pH 7 at 48C), NaCl (150 mM), glycerol (20%, v/v) . Proteins were drop frozen into liquid-N 2 until use. His 6 -SlAcs or His 6 -SlAcs S608T activity was assessed using a coupled spectrophotometric assay as described above. The above procedure was performed in triplicate Dual O-Ser, N-Lys acetylation control of an acyl-CoA ligase 591 with error bars of activity assays representing technical triplicates of a biological replicate.
